Table 1.

Overview and summary of previous papers by the authors of this paper

Authors	Comments
Hinz5	Use of serotonin and dopamine precursors guided by organic cation transporter optimization in the treatment of depression.
Trachte et al14	This is written by the chairman of the research committee, University of Minnesota Medical School, Duluth, MN, based on laboratory data provided by and in collaboration with Marty Hinz. The paper documents the response of urinary serotonin and dopamine to administration of L-tyrosine in a large group.
Hinz et al6	Publishing of a new organic cation transporter model relating to monoamine transport.
Hinz et al7	Discusses the validity of day to day reproducibility of spot baseline urinary serotonin and dopamine samples in the same subject. Findings were that testing differs significantly from day to day in the same subject and is not reproducible.
Hinz et al8	Differentiation of major affective disorder from depression-dominant bipolar disorder and treatment with serotonin and dopamine amino acid precursors, guided by transporter assay optimization.
Stein et al13	A treatment protocol for treatment of Crohn’s disease with amino acids guided by organic cation transporter functional status determination.
Hinz et al9	Treatment of attention deficit hyperactivity disorder with serotonin and dopamine amino acid precursors, guided by organic cation transporter assay optimization.
Hinz et al10	Discusses the validity of day to day reproducibility of spot baseline urinary norepinephrine and epinephrine samples in the same subject. Findings were that testing differs significantly from day to day in the same subject and is not reproducible.
Hinz et al11	Management of Parkinson disease with organic cation transporter optimization in a manner that allows for management and control of all problems associated directly and indirectly with L-dopa administration during treatment.
Hinz et al12	A paper written in response to an editor invitation. The paper reviews a paper titled, “Non-validity and clinical relevance of neurotransmitter testing”.